UpHealth Group Limited (SGX:GRQ)
Singapore · Delayed Price · Currency is SGD 0.1300
0.00 (0.00%)
At close: Sep 21, 2026
UpHealth Group Ratios and Metrics
Market cap in millions SGD. Fiscal year is January - December.
Millions SGD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 18, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 20 | 20 | 29 | 21 | 33 | 59 | |
Market Cap Growth | -16.67% | -32.14% | 37.06% | -35.00% | -44.30% | 11.27% |
Enterprise Value | 64 | -5 | 2 | 18 | 50 | 65 |
Last Close Price | 0.13 | 0.13 | 0.20 | 0.14 | 0.22 | 0.40 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 18, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | - | - | - | 5.75 |
Forward PE | - | 5.97 | 5.97 | 5.97 | 5.97 | 6.05 |
PS Ratio | 0.65 | - | - | - | 0.87 | 1.92 |
PB Ratio | 0.32 | 0.30 | 0.57 | 0.38 | 0.45 | 0.88 |
P/TBV Ratio | - | 0.30 | 0.57 | 0.38 | 0.46 | 0.88 |
P/FCF Ratio | 3.12 | - | - | 16.76 | - | - |
P/OCF Ratio | 2.85 | - | - | 7.59 | 22.26 | 42.43 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 18, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 2.15 | - | - | - | 1.31 | 2.11 |
EV/EBITDA Ratio | 87.85 | - | - | 9.66 | 54.05 | 5.09 |
EV/EBIT Ratio | - | - | - | - | - | 6.06 |
EV/FCF Ratio | 10.29 | - | - | 14.11 | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 18, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 1.02 | - | - | 0.18 | 0.16 | 0.20 |
Debt / EBITDA Ratio | 85.54 | - | - | 3.83 | 5.46 | 0.97 |
Debt / FCF Ratio | 10.02 | - | - | 7.93 | - | - |
Net Debt / Equity Ratio | 0.74 | -0.37 | -0.93 | 0.14 | 0.12 | 0.10 |
Net Debt / EBITDA Ratio | -55.95 | 4.90 | 7.91 | 4.18 | 9.20 | 0.51 |
Net Debt / FCF Ratio | 7.20 | 3.91 | 3.97 | 6.10 | -3.46 | -9.85 |
Asset Turnover | 0.29 | - | - | - | 0.41 | 0.41 |
Inventory Turnover | - | - | - | - | 1.29 | 0.77 |
Quick Ratio | 0.98 | 36.55 | 37.26 | 0.25 | 0.33 | 0.64 |
Current Ratio | 1.21 | 40.31 | 40.69 | 2.20 | 2.55 | 3.36 |
Return on Equity (ROE) | -6.98% | -2.30% | -8.47% | -1.20% | -2.80% | 18.61% |
Return on Assets (ROA) | -1.69% | -6.44% | -6.91% | -0.38% | -1.26% | 8.99% |
Return on Invested Capital (ROIC) | -2.60% | -27.05% | -21.19% | -0.74% | -2.43% | 18.14% |
Return on Capital Employed (ROCE) | -2.40% | -9.30% | -14.10% | -0.80% | -2.20% | 13.80% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 18, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | -22.18% | -6.84% | -77.14% | -19.89% | -6.00% | 17.39% |
FCF Yield | 32.06% | -31.62% | -40.94% | 5.97% | -7.40% | -1.11% |
Dividend Yield | - | - | - | - | - | 2.15% |
Payout Ratio | - | - | - | - | - | 28.10% |
Buyback Yield / Dilution | - | - | - | - | - | -1.71% |
Total Shareholder Return | - | - | - | - | - | 0.44% |